Literature DB >> 16697673

Hypopituitarism after acute brain injury.

Randall J Urban1.   

Abstract

Acute brain injury has many causes, but the most common is trauma. There are 1.5-2.0 million traumatic brain injuries (TBI) in the United States yearly, with an associated cost exceeding 10 billion dollars. TBI is the most common cause of death and disability in young adults less than 35 years of age. The consequences of TBI can be severe, including disability in motor function, speech, cognition, and psychosocial and emotional skills. Recently, clinical studies have documented the occurrence of pituitary dysfunction after TBI and another cause of acute brain injury, subarachnoid hemorrhage (SAH). These studies have consistently demonstrated a 30-40% occurrence of pituitary dysfunction involving at least one anterior pituitary hormone following a moderate to severe TBI or SAH. Growth hormone (GH) deficiency is the most common pituitary hormone disorder, occurring in approximately 20% of patients when multiple tests of GH deficiency are used. Within 7-21 days of acute brain injury, adrenal insufficiency is the primary concern. Pituitary function can fluctuate over the first year after TBI, but it is well established by 1 year. Studies are ongoing to assess the effects of hormone replacement on motor function and cognition in TBI patients. Any subject with a moderate to severe acute brain injury should be screened for pituitary dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 16697673     DOI: 10.1016/j.ghir.2006.03.017

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  9 in total

1.  Low and Normal IGF-1 Levels in Patients with Chronic Medical Disorders (CMD) is Independent of Anterior Pituitary Hormone Deficiencies: Implications for Treating IGF-1 Abnormal Deficiencies with CMD.

Authors:  E Braverman; M Oscar-Berman; R Lohmann; R Kennedy; M Kerner; K Dushaj; K Blum
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-09

Review 2.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

Review 3.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  Acute Hypothalamic-pituitary-adrenal response in traumatic brain injury with and without extracerebral trauma.

Authors:  Juan A Llompart-Pou; Joan M Raurich; Jon Pérez-Bárcena; Antonia Barceló; Jordi Ibáñez; José I Ayestarán
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  The Effects of Estrogen Receptors' Antagonist on Brain Edema, Intracranial Pressure and Neurological Outcomes after Traumatic Brain Injury in Rat.

Authors:  Fatemeh Dehghan; Mohammad Khaksari; Elham Abbasloo; Nader Shahrokhi
Journal:  Iran Biomed J       Date:  2015-05-30

6.  The effect and mechanism of growth hormone replacement on cognitive function in rats with traumatic brain injury.

Authors:  Hao Zhang; Mengqi Han; Xiaonian Zhang; Xinting Sun; Feng Ling
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

7.  The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in rats.

Authors:  Elham Abbasloo; Fatemeh Dehghan; Mohammad Khaksari; Hamid Najafipour; Reza Vahidi; Shahriar Dabiri; Gholamreza Sepehri; Gholamreza Asadikaram
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

8.  Occult endocrine dysfunction in patients of cerebrovascular accident.

Authors:  K V S Hari Kumar; Sandeep Kumar; Faiz M H Ahmad
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

Review 9.  Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood.

Authors:  Ginevra Corneli; Valentina Gasco; Flavia Prodam; Silvia Grottoli; Gianluca Aimaretti; Ezio Ghigo
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.